Improving Clinical Trial Awareness in NSCLC: Pilot Testing A Novel Healthcare IT Platform for Incorporating Education at the Point of Care
Not Applicable
Completed
- Conditions
- Non-Small Cell Lung Carcinoma (NSCLC)
- Registration Number
- NCT02558998
- Lead Sponsor
- Abramson Cancer Center at Penn Medicine
- Brief Summary
The objective of this study is to 1) evaluate the impact of a novel individualized care planning/ educational technology (the On Q Care Planning System or CPS) on oncology patient and provider knowledge, attitudes and beliefs about Non-Small Cell Lung Carcinoma (NSCLC) clinical trials, as well as 2) to evaluate the impact of the On Q CPS on patient referral to and enrollment in NSCLC clinical trials.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
- All participants must be 18 years of age or older.
- Patient participants must have Stage III, IV and/or recurrent NSCLC.
- Patient participants must be at a point of treatment initiation/change or evaluation for treatment initiation/change
- Patients must have working email address and internet access
Exclusion Criteria
- Any participant who cannot understand written or spoken English.
- Any participant who is not competent to provide informed consent for study participation per the investigator.
- Any participant who cannot be present for the related study visits and/or complete the post-test assessment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Number of patient who completed surveys 8 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Abramson Cancer Center of the University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States